(Q39564560)

13 September 2017

Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. (English)

1 reference

13 September 2017

1 reference

1 reference

von Bonin A

1

1 reference

13 September 2017

Ehrlich S

series ordinal

2

1 reference

13 September 2017

Malcherek G

series ordinal

3

1 reference

13 September 2017

Fleischer B

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

European Journal of Immunology

13 September 2017

1 reference

13 September 2017

25

1 reference

13 September 2017

10

1 reference

13 September 2017

2894-2898

1 reference

The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

How do T-cell receptors, MHC molecules and superantigens get together?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

T-cell responses to Mls and to bacterial proteins that mimic its behavior

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.1830251028

1 reference

7 January 2021

Superantigens interact with MHC class II molecules outside of the antigen groove.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Characterization of Naturally Occurring Minor Histocompatibility Peptides Including H-4 and H-Y

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

A versatile method to produce antibodies to human T cell receptor Vβ segments: frequency determination of human Vβ2+ T cells that react with toxic-shock syndrome toxin-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Zinc regulates the function of two superantigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251028

7 January 2021

Identifiers

DOI

10.1002/EJI.1830251028

1 reference

release_3anbloeazzgcjnlc2a5snnnzwm

13 September 2017

0 references

1 reference